Drug profile · INN
sodium benzoate
PROHIPPUR
sodium benzoate (PROHIPPUR) is a unknown. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
Drug details — sodium benzoate
- US status
- approved
- Class
- Alimentary tract and metabolism (A16)
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
sodium benzoate (PROHIPPUR) is a unknown. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sodium benzoate?
sodium benzoate (PROHIPPUR) is a unknown. Associated with MAIA Biotechnology. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sodium benzoate?
PROHIPPUR is a marketed brand name for sodium benzoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium benzoate?
sodium benzoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.